Ankasa Regenerative Therapeutics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 5

Employees
  • Latest Deal Type
  • Later Stage VC

  • (Cancelled)
  • Investors
  • 5

Ankasa Regenerative Therapeutics General Information

Description

Developer of protein-based stem cell activation therapies intended to improve tissue repair and regeneration. The company's therapies enhance the osteogenic properties of patient-derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation, enabling clinicians to reduce the rate of revision surgeries and their attendant complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
  • 11099 North Torrey Pines Road
  • Suite 290, La Jolla
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000

Ankasa Regenerative Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ankasa Regenerative Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Jan-2021 Cancelled Generating Revenue
3. Later Stage VC 13-Oct-2020 000 000.00 000.00 Completed Generating Revenue
2. Grant 01-Aug-2019 $6.08M $9.5M Completed Generating Revenue
1. Early Stage VC (Series A) 30-Jul-2015 $9.5M $9.5M 000.00 Completed Generating Revenue
To view Ankasa Regenerative Therapeutics’s complete valuation and funding history, request access »

Ankasa Regenerative Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
To view Ankasa Regenerative Therapeutics’s complete cap table history, request access »

Ankasa Regenerative Therapeutics Patents

Ankasa Regenerative Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200399588-A1 Wnt compositions and methods of process from serum-free culturing conditions Pending 01-Aug-2017 0000000000
CA-3071638-A1 Wnt compositions and methods of process from serum-free culturing conditions Pending 01-Aug-2017 000000000
AU-2018309026-A1 Wnt compositions and methods of process from serum-free culturing conditions Pending 01-Aug-2017 000000000
GB-202001567-D0 Wnt compositions and methods of process from serum-free culturing Pending 01-Aug-2017 000000000
GB-2581882-A Wnt compositions and methods of process from serum-free culturing Pending 01-Aug-2017 C12N5/0031 0
To view Ankasa Regenerative Therapeutics’s complete patent history, request access »

Ankasa Regenerative Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Jill Helms Ph.D Co-Founder & Founding Chief Scientific Officer
Scott Burkette Co-Founder
Gloria Matthews Ph.D Chief Medical Officer
Sanford Madigan Ph.D Co-Founder, Chief Executive Officer & Board Member
David Lacey MD Co-Founder & Chairman of Scientific Advisory Board
To view Ankasa Regenerative Therapeutics’s complete executive team members history, request access »

Ankasa Regenerative Therapeutics Board Members (5)

Name Representing Role Since
Andre Kobelt Ph.D Self Board Member 000 0000
David Lacey MD Self Co-Founder & Chairman of Scientific Advisory Board 000 0000
Kevin Kinsella Avalon Ventures Board Member 000 0000
Sanford Madigan Ph.D Self Co-Founder, Chief Executive Officer & Board Member 000 0000
Tighe Reardon Self Board Member 000 0000
To view Ankasa Regenerative Therapeutics’s complete board members history, request access »

Ankasa Regenerative Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ankasa Regenerative Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Regenerative Medicine Government 000 0000 000000 0
Avalon Ventures Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
Heraeus Holding Corporation Minority 000 0000 000000 0
Stanford University Venture Fund Venture Capital Minority 000 0000 000000 0
To view Ankasa Regenerative Therapeutics’s complete investors history, request access »